Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 6 studies | 28% ± 8% | |
endothelial cell | 4 studies | 18% ± 2% | |
cardiac muscle cell | 4 studies | 22% ± 2% | |
basal cell | 4 studies | 23% ± 4% | |
adipocyte | 4 studies | 25% ± 13% | |
squamous epithelial cell | 3 studies | 30% ± 15% | |
astrocyte | 3 studies | 19% ± 2% | |
enterocyte | 3 studies | 23% ± 1% | |
goblet cell | 3 studies | 18% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestine | 4 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3374.15 | 1445 / 1445 | 100% | 50.25 | 183 / 183 |
pancreas | 100% | 2793.30 | 328 / 328 | 100% | 47.12 | 178 / 178 |
liver | 100% | 3969.21 | 226 / 226 | 99% | 53.02 | 403 / 406 |
intestine | 100% | 4499.70 | 966 / 966 | 99% | 89.65 | 523 / 527 |
kidney | 100% | 5164.04 | 89 / 89 | 99% | 61.48 | 893 / 901 |
bladder | 100% | 2682.71 | 21 / 21 | 99% | 64.05 | 499 / 504 |
stomach | 100% | 3416.99 | 359 / 359 | 99% | 75.65 | 283 / 286 |
skin | 100% | 2576.18 | 1809 / 1809 | 99% | 43.30 | 467 / 472 |
prostate | 100% | 2358.59 | 244 / 245 | 99% | 40.84 | 496 / 502 |
lung | 99% | 2789.66 | 574 / 578 | 99% | 44.67 | 1141 / 1155 |
thymus | 100% | 2628.76 | 652 / 653 | 98% | 29.97 | 594 / 605 |
brain | 97% | 1722.52 | 2568 / 2642 | 100% | 32.71 | 705 / 705 |
adrenal gland | 100% | 2852.11 | 258 / 258 | 95% | 28.64 | 219 / 230 |
breast | 100% | 2118.07 | 458 / 459 | 94% | 25.54 | 1048 / 1118 |
uterus | 94% | 1173.21 | 159 / 170 | 99% | 50.09 | 455 / 459 |
ovary | 51% | 459.11 | 92 / 180 | 97% | 30.98 | 419 / 430 |
eye | 0% | 0 | 0 / 0 | 100% | 62.66 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 42.05 | 29 / 29 |
muscle | 100% | 9761.14 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2696.98 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 62.21 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 33.10 | 1 / 1 |
adipose | 100% | 2294.10 | 1201 / 1204 | 0% | 0 | 0 / 0 |
heart | 99% | 6986.59 | 852 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 1501.38 | 1306 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 91% | 1894.06 | 850 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030518 | Biological process | nuclear receptor-mediated steroid hormone signaling pathway |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0001650 | Cellular component | fibrillar center |
GO_0045171 | Cellular component | intercellular bridge |
GO_0015630 | Cellular component | microtubule cytoskeleton |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0003707 | Molecular function | nuclear steroid receptor activity |
GO_0004879 | Molecular function | nuclear receptor activity |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0034056 | Molecular function | estrogen response element binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005496 | Molecular function | steroid binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ESRRA |
Protein name | Estrogen-related receptor alpha Estrogen related receptor alpha Steroid hormone receptor ERR1 (Estrogen receptor-like 1) (Estrogen-related receptor alpha) (ERR-alpha) (Nuclear receptor subfamily 3 group B member 1) ESRRA protein ESRRA protein (Estrogen-related nuclear receptor alpha) (Estrogen-related receptor alpha) (HCG2016877, isoform CRA_b) |
Synonyms | hCG_2016877 ERR1 NR3B1 ESRL1 |
Description | FUNCTION: Binds to an ERR-alpha response element (ERRE) containing a single consensus half-site, 5'-TNAAGGTCA-3'. Can bind to the medium-chain acyl coenzyme A dehydrogenase (MCAD) response element NRRE-1 and may act as an important regulator of MCAD promoter. Binds to the C1 region of the lactoferrin gene promoter. Requires dimerization and the coactivator, PGC-1A, for full activity. The ERRalpha/PGC1alpha complex is a regulator of energy metabolism. Induces the expression of PERM1 in the skeletal muscle. . |
Accessions | ENST00000468670.2 F5GWT5 Q96I02 A0A6E1WCP9 A8CGI6 ENST00000539594.5 ENST00000545035.1 ENST00000406310.6 ENST00000000442.11 [P11474-1] Q569H8 ENST00000677967.1 [P11474-2] ENST00000405666.5 [P11474-1] P11474 F5H0E9 H0YGT3 Q6GMQ8 |